The University of Ghana Medical School (UGMS) has dismissed as false a social media publication claiming that its researchers have developed a cassava-based compound capable of reversing Type 2 diabetes.

In an official notice issued on Sunday, January 18, 2026, UGMS stated that it has not conducted any study, isolated any compound, or developed any substance known as “cassavarin,” as alleged in the circulating publication.

The medical school further clarified that it has not carried out any clinical trials related to such a compound and has not been involved in any regulatory approval processes, pharmaceutical litigation, or licensing arrangements referenced in the claims.

According to UGMS, all assertions contained in the publication, including those relating to scientific breakthroughs and regulatory actions, are entirely fabricated.

“The University of Ghana Medical School maintains the highest standards of scientific integrity and ethical research practice,” the notice said.

UGMS advised members of the public to rely solely on information released through official University of Ghana communication channels, warning against misinformation that could mislead patients and the general public.

The medical school also stated that it strongly dissociates itself from the false claims and is taking appropriate steps to address the matter.